Yu Yuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu Yuan has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Guang Huang
Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA
4 shared publications - Debopam Chakrabarti
Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32826, USA
3 shared publications Nameer Ezzat
Department of Chemistry, University of Central Florida
3 shared publicationsClaribel Murillo Solano
Division of Molecular Microbiology, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, 32826, USA
2 shared publications- Ebrahim H. Ghazvini Zadeh
Departments of Cell Biology and of Biochemistry, University of Texas Southwestern Medical, Dallas, TX, United States
2 shared publications Hui Min
Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida 33612, United States
2 shared publications
Latest Publications
- 4 September 2026
- Published by Elsevier in Molecular Catalysis
- Vol. 604
Cooperative H₂ activation by N₂-bound boron-containing frustrated Lewis pairs: theoretical insights into initial step leading to N2 reduction
- 4 September 2026
- Published by Elsevier in Molecular Catalysis
- Vol. 604
Cooperative H₂ activation by N₂-bound boron-containing frustrated Lewis pairs: theoretical insights into initial step leading to N2 reduction
- Top Cited Papers
- 29 May 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (11) , 12767-12804
Harnessing the Quinoline Scaffold toward Discovery and Development of Antimalarials
The quinoline scaffold, a well-established privileged structure, continues to play a central role in antimalarial drug discovery. This perspective presents a comprehensive summary and discussion of the antimalarial targets of quinoline derivatives, including heme detoxification, PfCDPK1, PfChoK, PfPI4K, PfPK6, proteases, PfLDH, PfHSP, PfCRT, PfeEF2, PfPFT, and the cytochrome bc1 complex. Particular emphasis is placed on promising analogs with dual-stage or multistage activity, potent efficacy against drug-resistant Plasmodium falciparum strains, and favorable physicochemical and pharmacokinetic profiles, together with robust in vivo performance. Emerging safety considerations, such as cardiotoxicity (hERG inhibition), hepatotoxicity, and metabolite formation, are also highlighted. In addition, key challenges and future directions are discussed, including exploration of new biological targets and the application of modern discovery strategies such as molecular hybridization, drug repurposing, prodrug design, and ionic liquids. Overall, this perspective aims to provide insights that support the continued development of affordable, safe, and effective quinoline-based antimalarial therapeutics.
- 29 May 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (11) , 12767-12804
Top Cited PapersHarnessing the Quinoline Scaffold toward Discovery and Development of Antimalarials
The quinoline scaffold, a well-established privileged structure, continues to play a central role in antimalarial drug discovery. This perspective presents a comprehensive summary and discussion of the antimalarial targets of quinoline derivatives, including heme detoxification, PfCDPK1, PfChoK, PfPI4K, PfPK6, proteases, PfLDH, PfHSP, PfCRT, PfeEF2, PfPFT, and the cytochrome bc1 complex. Particular emphasis is placed on promising analogs with dual-stage or multistage activity, potent efficacy against drug-resistant Plasmodium falciparum strains, and favorable physicochemical and pharmacokinetic profiles, together with robust in vivo performance. Emerging safety considerations, such as cardiotoxicity (hERG inhibition), hepatotoxicity, and metabolite formation, are also highlighted. In addition, key challenges and future directions are discussed, including exploration of new biological targets and the application of modern discovery strategies such as molecular hybridization, drug repurposing, prodrug design, and ionic liquids. Overall, this perspective aims to provide insights that support the continued development of affordable, safe, and effective quinoline-based antimalarial therapeutics.
- Open Access
- 21 March 2026
- Published by Elsevier in SSRN Electronic Journal
Cooperative H₂ activation by N₂-bound Boron-Containing Frustrated Lewis Pairs: Theoretical Insights into initial step leading to N2 Reduction
N₂ is abundant in the atmosphere; however, its activation under mild conditions to produce useful compounds remains a major challenge for industrial and practical applications. Here, we theoretically explore boron-containing frustrated Lewis pairs (FLPs) as a platform for room-temperature N₂ activation through systematic combinations of Lewis acids (LA) and Lewis bases (LB). We report a previously unrecognized synergistic mechanism in which an N₂-bound FLP cooperatively promotes heterolytic H₂ cleavage. Analysis of 24 unique geometries reveals how this step contributes to the gradual weakening of the N≡N triple bond, providing a potential route toward N₂ reduction. Among the systems investigated, an FLP containing –(CF₃)₃ substituents at the boron center and –(tBu)₃ at the phosphorus center is predicted to be particularly effective, enabling heterolytic H₂ activation with a computed free-energy barrier of 15.4 kcal mol⁻¹, suggesting that the activation can occur efficiently under mild conditions. Detailed electronic-structure analysis identifies the geometric, electronic, and thermodynamic factors governing this process. Systematic modification of the LA and LB sites reveals structure–property correlations linking substituent effects and dipole character to catalytic activity, providing practical design principles for tuning FLP catalysts. These findings introduce a new mechanistic framework for FLP-mediated H₂ activation in N₂-bound systems and provide guidance for the rational design of catalysts targeting mild-condition N₂ activation.
- 21 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessCooperative H₂ activation by N₂-bound Boron-Containing Frustrated Lewis Pairs: Theoretical Insights into initial step leading to N2 Reduction
N₂ is abundant in the atmosphere; however, its activation under mild conditions to produce useful compounds remains a major challenge for industrial and practical applications. Here, we theoretically explore boron-containing frustrated Lewis pairs (FLPs) as a platform for room-temperature N₂ activation through systematic combinations of Lewis acids (LA) and Lewis bases (LB). We report a previously unrecognized synergistic mechanism in which an N₂-bound FLP cooperatively promotes heterolytic H₂ cleavage. Analysis of 24 unique geometries reveals how this step contributes to the gradual weakening of the N≡N triple bond, providing a potential route toward N₂ reduction. Among the systems investigated, an FLP containing –(CF₃)₃ substituents at the boron center and –(tBu)₃ at the phosphorus center is predicted to be particularly effective, enabling heterolytic H₂ activation with a computed free-energy barrier of 15.4 kcal mol⁻¹, suggesting that the activation can occur efficiently under mild conditions. Detailed electronic-structure analysis identifies the geometric, electronic, and thermodynamic factors governing this process. Systematic modification of the LA and LB sites reveals structure–property correlations linking substituent effects and dipole character to catalytic activity, providing practical design principles for tuning FLP catalysts. These findings introduce a new mechanistic framework for FLP-mediated H₂ activation in N₂-bound systems and provide guidance for the rational design of catalysts targeting mild-condition N₂ activation.
- 23 December 2022
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 25 (1) , 31-36
Total Synthesis of Polysubstituted γ-Butyrolactone Lignans (−)-Hinokinin, (−)-Bicubebin B, and (−)-Isodeoxypodophyllotoxin via Oxime Carbonate Formation
The diverse structures and profound biological activities of lignan natural products have enticed significant effort in the exploration of new methodologies for their total synthesis. We have prepared gamma-butyrolactone oximes from readily available delta-nitro alcohols via Boc(2)O mediated cyclization. The mild conditions are compatible with a wide range of functional groups, and this methodology has been applied to the total synthesis of five lignan natural products.
- 23 December 2022
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 25 (1) , 31-36
Total Synthesis of Polysubstituted γ-Butyrolactone Lignans (−)-Hinokinin, (−)-Bicubebin B, and (−)-Isodeoxypodophyllotoxin via Oxime Carbonate Formation
The diverse structures and profound biological activities of lignan natural products have enticed significant effort in the exploration of new methodologies for their total synthesis. We have prepared gamma-butyrolactone oximes from readily available delta-nitro alcohols via Boc(2)O mediated cyclization. The mild conditions are compatible with a wide range of functional groups, and this methodology has been applied to the total synthesis of five lignan natural products.
- 2 December 2022
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 65 (24) , 16432-16450
Development of SOS1 Inhibitor-Based Degraders to Target KRAS-Mutant Colorectal Cancer
Direct blockade of KRAS driver mutations in colorectal cancer (CRC) has been challenging. Targeting SOS1, a guanine nucleotide exchange factor, has arisen as an attractive approach for KRAS-mutant CRC. Here, we describe the development of novel SOS1 degraders and their activity in patient-derived CRC organoids (PDO). The design of these degraders as proteolysis-targeting chimera was based on the crystal structures of cereblon and SOS1. The synthesis used the 6- and 7-OH groups of a quinazoline core as anchor points to connect lenalidomide. Fifteen compounds were screened for SOS1 degradation. P7 was found to have up to 92% SOS1 degradation in both CRC cell lines and PDOs with excellent specificity. SOS1 degrader P7 demonstrated superior activity in inhibiting CRC PDO growth with IC50 5 times lower than that of SOS1 inhibitor BI3406. In summary, we developed new SOS1 degraders and demonstrated SOS1 degradation as a feasible therapeutic strategy for KRAS-mutant CRC.
- 2 December 2022
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 65 (24) , 16432-16450
Development of SOS1 Inhibitor-Based Degraders to Target KRAS-Mutant Colorectal Cancer
Direct blockade of KRAS driver mutations in colorectal cancer (CRC) has been challenging. Targeting SOS1, a guanine nucleotide exchange factor, has arisen as an attractive approach for KRAS-mutant CRC. Here, we describe the development of novel SOS1 degraders and their activity in patient-derived CRC organoids (PDO). The design of these degraders as proteolysis-targeting chimera was based on the crystal structures of cereblon and SOS1. The synthesis used the 6- and 7-OH groups of a quinazoline core as anchor points to connect lenalidomide. Fifteen compounds were screened for SOS1 degradation. P7 was found to have up to 92% SOS1 degradation in both CRC cell lines and PDOs with excellent specificity. SOS1 degrader P7 demonstrated superior activity in inhibiting CRC PDO growth with IC50 5 times lower than that of SOS1 inhibitor BI3406. In summary, we developed new SOS1 degraders and demonstrated SOS1 degradation as a feasible therapeutic strategy for KRAS-mutant CRC.
- 1 December 2020
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 32 (07) , 689-692
Total Synthesis of (±)-Phaeocaulisin D
The tropone sesquiterpene phaeocaulisin D, isolated from the rhizomes of Curcuma phaeocaulis, has previously been shown to inhibit nitric oxide production in macrophages. A total synthesis of phaeocaulisin D was accomplished by using an intramolecular cyclization–dearomatization as a key step. The highlights of the synthesis are effective formation of the 5–7 fused tropone system, and selective methylation of a late-stage intermediate.
- 1 December 2020
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 32 (07) , 689-692
Total Synthesis of (±)-Phaeocaulisin D
The tropone sesquiterpene phaeocaulisin D, isolated from the rhizomes of Curcuma phaeocaulis, has previously been shown to inhibit nitric oxide production in macrophages. A total synthesis of phaeocaulisin D was accomplished by using an intramolecular cyclization–dearomatization as a key step. The highlights of the synthesis are effective formation of the 5–7 fused tropone system, and selective methylation of a late-stage intermediate.
- 6 October 2020
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (20) , 11756-11785
Synthesis, Structure–Activity Relationship, and Antimalarial Efficacy of 6-Chloro-2-arylvinylquinolines
There is an urgent need to develop new efficacious antimalarials to address the emerging drug-resistant clinical cases. Our previous phenotypic screening identified styrylquinoline UCF501 as a promising antimalarial compound. To optimize UCF501, we herein report a detailed structure-activity relationship study of 2-arylvinylquinolines, leading to the discovery of potent, low nanomolar antiplasmodial compounds against a P. falciparum CQ-resistant Dd2 strain, with excellent selectivity profiles (RI < 1 and SI > 200). Several metabolically stable 2-arylvinylquinolines are identified as fast-acting agents that kill asexual blood stage parasites at the trophozoite phase, and the most promising compound 24 also demonstrates transmission blocking potential. Additionally, the monophosphate salt of 24 exhibits excellent in vivo antimalarial efficacy in the murine model without noticeable toxicity. Thus, the 2-arylvinylquinolines represent a promising class of antimalarial drug leads.
- 6 October 2020
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (20) , 11756-11785
Synthesis, Structure–Activity Relationship, and Antimalarial Efficacy of 6-Chloro-2-arylvinylquinolines
There is an urgent need to develop new efficacious antimalarials to address the emerging drug-resistant clinical cases. Our previous phenotypic screening identified styrylquinoline UCF501 as a promising antimalarial compound. To optimize UCF501, we herein report a detailed structure-activity relationship study of 2-arylvinylquinolines, leading to the discovery of potent, low nanomolar antiplasmodial compounds against a P. falciparum CQ-resistant Dd2 strain, with excellent selectivity profiles (RI < 1 and SI > 200). Several metabolically stable 2-arylvinylquinolines are identified as fast-acting agents that kill asexual blood stage parasites at the trophozoite phase, and the most promising compound 24 also demonstrates transmission blocking potential. Additionally, the monophosphate salt of 24 exhibits excellent in vivo antimalarial efficacy in the murine model without noticeable toxicity. Thus, the 2-arylvinylquinolines represent a promising class of antimalarial drug leads.
- 1 July 2020
- Published by Elsevier in Tetrahedron Letters
- Vol. 61 (30)
A concise and scalable synthesis of a novel l-allo-enduracididine derivative
- 1 July 2020
- Published by Elsevier in Tetrahedron Letters
- Vol. 61 (30)
A concise and scalable synthesis of a novel l-allo-enduracididine derivative
- 28 May 2019
- Published by Elsevier in Tetrahedron Letters
- Vol. 60 (26) , 1736-1740
Microwave-assisted, rapid synthesis of 2-vinylquinolines and evaluation of their antimalarial activity
- 28 May 2019
- Published by Elsevier in Tetrahedron Letters
- Vol. 60 (26) , 1736-1740
Microwave-assisted, rapid synthesis of 2-vinylquinolines and evaluation of their antimalarial activity